COV vs ECS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

COV

CLEO DIAGN FPO [COV]

45LOW

ECS

ECSBOTANIC FPO [ECS]

50MEDIUM

Score Breakdown

COV ECS
Technical
44
33
Catalyst
53
53
Sentiment
50
50
Fundamental
60
61
Momentum
64
53
Risk Gate
46
27

Key Metrics

COV Metric ECS
$63.8MMarket Cap$8.0M
122KAvg Volume (20d)1.4M
N/AShort InterestN/A
$0.90052-Week High$0.010
$0.33552-Week Low$0.003
-6.2%Daily Change-20.0%
$0.455Reference Price$0.004
-49.6%ROEN/A
-157.4%Profit MarginN/A

Active Signals

COV Signals

●RSI drifting toward oversold territory — worth watching
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (15 quarters)
●Strong revenue growth (+373%)
●Small-cap ($20-100M)

ECS Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic turning bearish from a high level — caution
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 20.0% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (16 quarters)
●Very high P/S ratio (2211.4x)

Ask Scout AI to compare COV and ECS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

COV vs ENP →COV vs IDX →COV vs NAN →COV vs PEB →COV vs PKY →
COV Full Analysis → ECS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).